Doug Besch, Chief Product and Chief Technology Officer at OptimizeRx
Consumers are increasingly learning about potential drug therapies from advertising across the media channels they use regularly – whether it be broadcast or streaming TV,…
Continue Reading
Strategic Acquisition Overview
Aptar, a global leader in drug and consumer product dosing, dispensing, and protection technologies, has announced the strategic acquisition of Sommaplast, a specialized provider of oral dosing pharma packaging solutions based in…
Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
Nicole Ventrone, Partner at Beghou
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running…
Continue Reading
What You Should Know:
– myTomorrows, a health technology company that connects patients with all possible pre-approval treatments, today announced the close of a $29 million financing with Avego. Avego’s growth equity investment will fuel…
Continue Reading
What You Should Know:
– Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series…
Continue Reading
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Aaron Brauser, General Manager Life Sciences at Carta Healthcare.
AI should work in…
The last day of HLTH is when the crowds thin out, the conversations go deeper, and the real discoveries start to emerge. Day 4 delivered smart insights, standout tech, and a look at where…
Continue Reading
Image Credit: NVIDIA
What You Should Know:
– NVIDIA today unveiled a massive expansion of its healthcare AI initiatives, rolling out new open models as part of the NVIDIA Clara platform and announcing foundational partnerships with…
Continue Reading
The following is a guest article by Jiang Li, CEO at Vivalink
Decentralized and hybrid clinical trials gained traction out of necessity. During the pandemic, many teams had to shift quickly to telehealth, remote monitoring,…
